Earnings Reports

Found 58,492 articles

• Genprex Provides Clinical and Corporate Update for Third Quarter 2018

  11/20/2018

  Filing of quarterly results for the third quarter ended September 30, 2018 on Form 10-Q with the Securities and Exchange Commission.

• Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results

  11/20/2018

  Earnings Call Scheduled for 8:00 a.m. ET on November 28, 2018

• Brooks Automation Reports Fourth Quarter Results of Fiscal Year Ended September 30, 2018

  11/19/2018

  Brooks Automation, Inc. today reported financial results for the fourth quarter and the fiscal year ended September 30, 2018.

• Agilent Technologies Reports Fourth-Quarter Fiscal Year 2018 Financial Results

  11/19/2018

  Agilent delivers outstanding quarter wrapping up an excellent 2018

• TraceLink Achieves 55% Overall Revenue Growth for Q3 2018

  11/19/2018

   TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced financial and company results for the third quarter of 2018.

• Egalet Reports Third Quarter 2018 Financial Results

  11/19/2018

  -- Highest quarterly revenue for SPRIX Nasal Spray and OXAYDO --

• InDex Pharmaceuticals Holding AB (publ) Interim Report January - September 2018

  11/19/2018

  Directed share issue strengthens the cash position ahead of the CONDUCT results

• BiondVax Issues Clarification Regarding Third Quarter 2018 Financial Results

  11/19/2018

  BiondVax is a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate.

• CytoSorbents Recognized Again as One of the Fastest Growing Companies in North America on Deloitte's 2018 Technology Fast 500™

  11/19/2018

  Strong international demand for the Company's CytoSorb blood purification technology to control deadly inflammation drives 267% revenue growth over the past three years

• Kodiak Sciences Announces Third Quarter 2018 Financial Results and Recent Business Highlights

  11/16/2018

  Kodiak Sciences Inc.today reported business highlights and financial results for the third quarter ended September 30, 2018.

• Torchmark Corporation Declares Dividend Payable on February 1, 2019

  11/16/2018

  Torchmark Corporation (NYSE: TMK) announced that its Board of Directors has declared a quarterly dividend of $.16 per share on all of the outstanding common stock of the Company held of record as of the close of business of the Company's transfer agent on January 4, 2019. 

• Prometic Reports Third Quarter 2018 Financial Results and Highlights

  11/15/2018

  Extension of maturity dates of Line of Credit and OID Loans to September 2024

• China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results

  11/15/2018

  China Pharma Holdings, Inc. announced today its financial results for the quarter ended September 30, 2018.

• Oragenics, Inc. Announces 3Q 2018 Financial Results and Provides Corporate Update

  11/15/2018

  Oragenics, Inc. announced financial results for the quarter ended September 30, 2018.

• Griffin-American Healthcare REIT IV Reports Third Quarter 2018 Results

  11/15/2018

  Griffin-American Healthcare REIT IV, Inc. today announced operating results for the company's third quarter ended Sept. 30, 2018.

• ForeverGreen Provides Financial Guidance for 2019 with a Focus on Increased Margins and Profitability

  11/15/2018

  The proficient Xpress model allows products to be shipped anywhere in the world

• Blue Cross Blue Shield of Massachusetts Announces Third Quarter 2018 Financial Results

  11/15/2018

  Blue Cross Blue Shield of Massachusetts (Blue Cross), Inc. and Blue Cross Blue Shield of Massachusetts HMO Blue, Inc. today reported a combined after-tax third quarter net income of $92.8 million on revenue of $2.0 billion (4.6% net margin). 

• NantHealth Reports 2018 Third-Quarter Financial Results

  11/15/2018

  Total Revenue in Q3 was $22.3 Million

• Aradigm Announces Third Quarter 2018 Financial Results

  11/15/2018

  The Company recorded $282,000 in revenue in the third quarter of 2018 compared with $2.7 million in revenue in the third quarter of 2017.

• Medicrea Reports Third-Quarter 2018 Results

  11/15/2018

  Third quarter sales increased by 14%